Skip to main content

Table 1 Patient characteristics

From: Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes

Age (years) 64.0 ± 11.1 [37–79]
Gender (male/female) 17/15
Body mass index (kg/m2) 26.0 ± 5.3
Duration of diabetes (years) 11.3 ± 12.8 [1–45]
Diabetes therapy  
Diet only 15 (47.0)
Sulfonylurea 9 (28.0)
Pioglitazone 5 (16.0)
Metformin 6 (19.0)
α-glucosidase inhibitor 3 (9.0)
Dipeptidyl peptidase-4 inhibitor 7 (22.0)
Insulin 5 (15.6)
Other treatments  
Lipid-lowering drugs 13 (41.0)
Antihypertensive drugs 14 (44.0)
Current smokers 8 (25.0)
Prevalence cardiovascular disease 7 (22.0)
Systolic blood pressure (mmHg) 135.1 ± 20.0
Diastolic blood pressure (mmHg) 78.3 ± 12.5
LDL-cholesterol (mg/dl) 121.3 ± 23.8
HDL-cholesterol (mg/dl) 50.5 ± 16.9
Triglyceride (mg/dl) 119.8 ± 60.1
HbA1c (%) 7.3 ± 0.5 [6.2-7.9]
1,5-anhydro-D-glucitol (μg/ml) 7.4 ± 3.5 [2.6-15.3]
Fasting plasma glucose (mg/dl) 128.1 ± 25.3 [75–185]
Immunoreactive insulin (μU/ml)a 8.4 ± 8.6
HOMA-IRa 2.6 ± 2.4
L_RHI 0.6 ± 0.2
  1. Data are mean ± SD [range], n, or (%). an = 27.
  2. LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment as an index of insulin resistance; L_RHI, the natural logarithmic scaled reactive hyperemia index.